LONG ANDREW G (Chief Financial Officer) received a stock award from INSYS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 4/23/2019ACC: 0001209191-19-025628
Officer· Chief Financial Officer
Since Aug 2018
+255K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
255K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.60K
Price / share
—
Trade value
—
% of position
106.0%
3/5/2018
10K→20.60K
Common Stock
Direct
Shares
+29K
Price / share
—
Trade value
—
% of position
140.8%
1/25/2019
20.60K→49.60K
Total
Net shares
+39.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2018 | A · Award | +10.60K | — | — | 106.0% | 10K | 20.60K |
| Common Stock Direct | 1/25/2019 | A · Award | +29K | — | — | 140.8% | 20.60K | 49.60K |
| Total | +39.60K | $0.00 | ||||||
Derivative Transactions2
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
42.40K shares
Shares
+42.40K
Strike price
8.06
Held after
42.40K
Exercisable
—
3/5/2018
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
173K shares
Shares
+173K
Strike price
3.81
Held after
173K
Exercisable
—
1/25/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock42.40K shares | 3/5/2018 | A · Award | +42.40K | 8.06 | — | 42.40K |
| Employee Stock Option (right to buy) Direct | Common Stock173K shares | 1/25/2019 | A · Award | +173K | 3.81 | — | 173K |